Equities Analysts Set Expectations for TRVI FY2029 Earnings
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) – Equities research analysts at B. Riley issued their FY2029 earnings per share estimates for Trevi Therapeutics in a research report issued on Thursday, February 13th. B. Riley analyst M. Mamtani anticipates that the company will earn ($0.95) per share for the year. The consensus estimate for Trevi […]
